Deucravacitinib in moderate to severe plaque psoriasis: liver transaminase results from the phase 3 POETYK PSO program. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 May 17];7(2):s116. Available from: https://skin.dermsquared.com/skin/article/view/1967